Cargando…
Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes
IMPORTANCE: Bariatric surgery is recommended for patients with severe obesity (body mass index ≥40) and type 2 diabetes (T2D). However, the most cost-effective treatment remains unclear and may depend on the patient’s T2D severity. OBJECTIVE: To estimate the cost-effectiveness of medical therapy, sl...
Autores principales: | Lauren, Brianna N., Lim, Francesca, Krikhely, Abraham, Taveras, Elsie M., Woo Baidal, Jennifer A., Bellows, Brandon K., Hur, Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845022/ https://www.ncbi.nlm.nih.gov/pubmed/35157054 http://dx.doi.org/10.1001/jamanetworkopen.2021.48317 |
Ejemplares similares
-
Prospective study of gut hormone and metabolic changes after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass
por: Arakawa, Rachel, et al.
Publicado: (2020) -
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023) -
Comparison of Ambulatory Health Care Costs and Use Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy
por: Lewis, Kristina H., et al.
Publicado: (2022) -
Association of Insurance Coverage With Adoption of Sleeve Gastrectomy vs Gastric Bypass for Patients Undergoing Bariatric Surgery
por: Howard, Ryan, et al.
Publicado: (2022) -
Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy
por: Tarride, Jean-Eric, et al.
Publicado: (2021)